The reimbursement decision speed for oncology new drugs in China and its determinant factors

INTRODUCTION: China has initiated national price negotiations to improve access to innovative drugs. Learning the factors that contributed to the time gap from marketing authorization to reimbursement leads to more clarity to decision-making, which remains under-researched in China. METHODS: We coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xingyue, Chen, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643204/
https://www.ncbi.nlm.nih.gov/pubmed/38026304
http://dx.doi.org/10.3389/fpubh.2023.1207739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643204/
https://www.ncbi.nlm.nih.gov/pubmed/38026304
http://dx.doi.org/10.3389/fpubh.2023.1207739

Ejemplares similares